- Home
- HASI vs EWTX Comparison
HASI vs EWTX Comparison
Compare HASI & EWTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HASI
- EWTX
- Stock Information
- Founded
- HASI 1981
- EWTX 2017
- Country
- HASI United States
- EWTX United States
- Employees
- HASI N/A
- EWTX N/A
- Industry
- HASI Real Estate Investment Trusts
- EWTX Biotechnology: Pharmaceutical Preparations
- Sector
- HASI Real Estate
- EWTX Health Care
- Exchange
- HASI Nasdaq
- EWTX Nasdaq
- Market Cap
- HASI 3.2B
- EWTX 2.6B
- IPO Year
- HASI 2013
- EWTX 2021
- Fundamental
- Price
- HASI $27.55
- EWTX $27.39
- Analyst Decision
- HASI Strong Buy
- EWTX Buy
- Analyst Count
- HASI 12
- EWTX 6
- Target Price
- HASI $39.67
- EWTX $44.83
- AVG Volume (30 Days)
- HASI 954.4K
- EWTX 818.6K
- Earning Date
- HASI 02-13-2025
- EWTX 02-20-2025
- Dividend Yield
- HASI 6.00%
- EWTX N/A
- EPS Growth
- HASI 358.98
- EWTX N/A
- EPS
- HASI 1.82
- EWTX N/A
- Revenue
- HASI $139,077,000.00
- EWTX N/A
- Revenue This Year
- HASI N/A
- EWTX N/A
- Revenue Next Year
- HASI $7.51
- EWTX N/A
- P/E Ratio
- HASI $15.17
- EWTX N/A
- Revenue Growth
- HASI 14.37
- EWTX N/A
- 52 Week Low
- HASI $22.59
- EWTX $14.90
- 52 Week High
- HASI $36.56
- EWTX $38.12
- Technical
- Relative Strength Index (RSI)
- HASI 45.92
- EWTX 47.43
- Support Level
- HASI $26.07
- EWTX $23.08
- Resistance Level
- HASI $28.47
- EWTX $30.30
- Average True Range (ATR)
- HASI 0.80
- EWTX 1.70
- MACD
- HASI 0.19
- EWTX 0.19
- Stochastic Oscillator
- HASI 58.04
- EWTX 59.70
About HASI Hannon Armstrong Sustainable Infrastructure Capital Inc.
HA Sustainable Infrastructure Capital Inc is a climate investment firm that actively partners with clients to deploy real assets that facilitate the energy transition. It invests in behind-the-meter (BTM) building or facility-specific distributed energy projects which reduce energy usage or cost, Grid-connected (GC) renewable energy projects that deploy cleaner energy sources, such as solar, solar-plus-storage, and onshore wind, to generate power production and Fuels, Transport & Nature projects.
About EWTX Edgewise Therapeutics Inc.
Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases.